BR112014027712B1 - Uso de heparina ou sulfato de heparano quimicamente modificados no tratamento da hemorragia pós-parto - Google Patents

Uso de heparina ou sulfato de heparano quimicamente modificados no tratamento da hemorragia pós-parto Download PDF

Info

Publication number
BR112014027712B1
BR112014027712B1 BR112014027712-5A BR112014027712A BR112014027712B1 BR 112014027712 B1 BR112014027712 B1 BR 112014027712B1 BR 112014027712 A BR112014027712 A BR 112014027712A BR 112014027712 B1 BR112014027712 B1 BR 112014027712B1
Authority
BR
Brazil
Prior art keywords
heparin
use according
chemically modified
heparan sulfate
solution
Prior art date
Application number
BR112014027712-5A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014027712A2 (pt
Inventor
Gunvor Ekman-Ordeberg
Anders Malmström
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of BR112014027712A2 publication Critical patent/BR112014027712A2/pt
Publication of BR112014027712B1 publication Critical patent/BR112014027712B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112014027712-5A 2012-05-08 2013-05-07 Uso de heparina ou sulfato de heparano quimicamente modificados no tratamento da hemorragia pós-parto BR112014027712B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261644036P 2012-05-08 2012-05-08
US61/644,036 2012-05-08
US201261668150P 2012-07-05 2012-07-05
US61/668,150 2012-07-05
PCT/SE2013/050510 WO2013169194A1 (en) 2012-05-08 2013-05-07 Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Publications (2)

Publication Number Publication Date
BR112014027712A2 BR112014027712A2 (pt) 2017-06-27
BR112014027712B1 true BR112014027712B1 (pt) 2023-12-19

Family

ID=49551063

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014027712-5A BR112014027712B1 (pt) 2012-05-08 2013-05-07 Uso de heparina ou sulfato de heparano quimicamente modificados no tratamento da hemorragia pós-parto

Country Status (16)

Country Link
US (1) US20150099703A1 (cg-RX-API-DMAC7.html)
EP (1) EP2846810A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015516415A (cg-RX-API-DMAC7.html)
CN (1) CN104284667A (cg-RX-API-DMAC7.html)
AU (1) AU2013260209A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014027712B1 (cg-RX-API-DMAC7.html)
CA (1) CA2868403A1 (cg-RX-API-DMAC7.html)
HK (1) HK1203377A1 (cg-RX-API-DMAC7.html)
IL (1) IL234752A0 (cg-RX-API-DMAC7.html)
MX (1) MX2014013449A (cg-RX-API-DMAC7.html)
MY (1) MY192330A (cg-RX-API-DMAC7.html)
NZ (1) NZ701419A (cg-RX-API-DMAC7.html)
RU (1) RU2014149230A (cg-RX-API-DMAC7.html)
SG (1) SG11201407346WA (cg-RX-API-DMAC7.html)
UA (1) UA117912C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013169194A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12502403B2 (en) 2020-02-17 2025-12-23 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
UA21707U (en) * 2006-12-18 2007-03-15 Valerii Ivanovych Linnikov Method for preventing and treating thrombophilia in course of gestation and postpartum
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
DK2794665T3 (da) * 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
CN104203256B (zh) * 2012-03-26 2017-11-24 迪乐方有限责任公司 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗
NZ631279A (en) * 2012-03-26 2016-06-24 Dilafor Ab Method for treatment of labor arrest

Also Published As

Publication number Publication date
RU2014149230A (ru) 2016-06-27
AU2013260209A1 (en) 2014-11-20
MX2014013449A (es) 2014-12-08
CN104284667A (zh) 2015-01-14
JP2015516415A (ja) 2015-06-11
CA2868403A1 (en) 2013-11-14
WO2013169194A1 (en) 2013-11-14
UA117912C2 (uk) 2018-10-25
US20150099703A1 (en) 2015-04-09
NZ701419A (en) 2016-04-29
SG11201407346WA (en) 2014-12-30
HK1203377A1 (en) 2015-10-30
EP2846810A1 (en) 2015-03-18
IL234752A0 (en) 2014-11-30
MY192330A (en) 2022-08-17
BR112014027712A2 (pt) 2017-06-27
EP2846810A4 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
KR102135485B1 (ko) 반복 다이사카라이드 단위를 포함하는 비-항응고 글리코스아미노글리칸 및 이의 의학적 용도
CN104244957B (zh) 用于治疗分娩停止的方法
US8524688B2 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
JP6234989B2 (ja) 分娩を誘発するための療法
US20150099703A1 (en) Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25G Requested change of headquarter approved

Owner name: DILAFOR AB (SE)

B15I Others concerning applications: loss of priority

Free format text: PERDA DAS PRIORIDADES US 61644,036 E US61/668,150 REIVINDICADAS NO PCT/SE2013/050510, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O E ART 2O DA RESOLUCAO INPI 179 DE 21/02/2017. ESTA PERDA SE DEU PELO FATO DE O DEPOSITANTE CONSTANTE DA PETICAO DE REQUERIMENTO DO PEDIDO PCT SER DISTINTO DAQUELES QUE DEPOSITARAM A PRIORIDADE REIVINDICADA E NAO APRESENTOU DOCUMENTO COMPROBATORIO DE CESSAO DENTRO DO PRAZO DE 60 DIAS A CONTAR DA DATA DA ENTRADA DA FASE NACIONAL, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 6O, E NO ART. 28 DA RESOLUCAO INPI-PR 77/2013.

B12F Other appeals [chapter 12.6 patent gazette]

Free format text: RECURSO: 870210083462 - 10/09/2021

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B09Y Publication of grant cancelled [chapter 9.1.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 9.1 NA RPI NO 2717 DE 31/01/2023 POR TER SIDO INDEVIDA.

B09Y Publication of grant cancelled [chapter 9.1.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 9.1.3 NA RPI NO 2721 DE 28/02/2023 POR TER SIDO INDEVIDA.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/05/2013, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.